A bipartisan group of six U.S. lawmakers, including one from Oregon, have called on the federal Drug Enforcement Administration to allow terminal patients to use psilocybin to ease anxieties or depression.
U.S. Rep. Earl Blumenauer, Democrat of Portland, a longtime advocate of decriminalizing drugs, spearheaded the letter sent this week to the agency’s administrator, Anne Milgram.
“Research demonstrates that psilocybin provides immediate, substantial and sustained relief from debilitating anxiety and depression in individuals with terminal illnesses,” the lawmakers wrote on Tuesday. “Individuals with advanced cancer that are also suffering from treatment-resistant anxiety and/or depression have been found to experience significant reductions in both anxiety and depression, and improvements in mood, following a single guided session of psilocybin-assisted therapy, with no safety concerns or clinically significant adverse effects.”...